Why Is Everyone Talking About Novavax Stock?
Any stock that skyrockets over 4,600% from the beginning of a year through early August is bound to create a lot of buzz in the investment community. Although biotech Novavax (NASDAQ: NVAX) has been around for decades and doesn't yet have a marketed product, its entry into the race for a COVID-19 vaccine has put the stock in the spotlight and has investors scrambling to snap up the shares.
Novavax stock has cooled off in the last few months, down 44% from the peak, as the market seemed to grow more cautious about formerly red-hot coronavirus stocks. But the company still has people talking about recent developments, and Novavax-watchers may be wondering if this is a buying opportunity. Here are some factors that could support that view.
Image source: Getty Images.
Source Fool.com
